OS Therapies IncorporatedOSTXNYSE

Revenue (LTM)

Net Income (LTM)

$-9M

-14.0% YoY

Free Cash Flow

$-7M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-0	-1↓27185.7%	-0↑99.9%	-0↓424.2%	-0↑34.1%
Operating Income	-0	-5↓85562.4%	-4↑8.1%	-4↑2.3%	-7↓56.9%
Net Income	-0	-7↓123016.8%	-6↑15.7%	-8↓24.6%	-9↓14.0%
EBITDA	-0	-5↓85548.1%	-4↑8.1%	-4↑2.4%	-7↓57.4%
EPS Diluted	-0.00	-0.33↓47042.9%	-0.28↑15.2%	-0.39↓39.3%	-0.52↓33.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	1,233	0↓100.0%	0↑112.3%	0↓77.3%	6↑14095.1%
Total Current Assets	1,676	0↓100.0%	0↑58.8%	1↑59.0%	6↑600.4%
Total Assets	1,678	0↓100.0%	1↑56.2%	1↑56.8%	6↑594.0%
Total Current Liabilities	2,103	3↓99.8%	6↑75.8%	25↑302.0%	5↓81.3%
Total Liabilities	8,005	12↓99.9%	18↑53.4%	25↑37.4%	5↓80.9%
Total Equity	-6,327	-11↑99.8%	-18↓53.3%	-24↓36.8%	1↑103.4%
Total Debt	6,773	7↓99.9%	10↑46.3%	15↑41.2%	0
Net Debt	5,540	7↓99.9%	10↑45.5%	15↑43.2%	-6↓138.0%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-2,413	-4↑99.8%	-4↑13.9%	-3↑20.7%	-7↓142.2%
Capital Expenditure	-2	-0↑99.4%	0	0	0
Free Cash Flow	-2,415	-4↑99.8%	-4↑14.1%	-3↑20.7%	-7↓142.2%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	1,233	-1↓100.1%	0↑107.9%	-0↓246.1%	5↑4246.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance